International Project Creates Comprehensive Cancer Models to Advance Personalized Treatments

Researchers supported by the US National Institutes of Health (NIH) have launched a groundbreaking international initiative to develop an extensive repository of human cancer models. This database includes samples from thousands of patients representing 25 different cancer types. The goal is to accelerate drug development and enable more precise, personalized cancer treatments.

The models are derived from actual tumor tissues, allowing scientists to test how various cancers respond to treatments before clinical trials in humans. This approach aims to identify effective therapies for specific patient groups and improve treatment strategies. The repository will be accessible to the global research community, fostering collaboration among medical centers and researchers worldwide.

Although still in the research phase and not yet available as a treatment, experts believe this infrastructure could significantly shorten drug development timelines. By using models closely resembling real patient tumors, the project hopes to reduce trial-and-error in drug testing and increase the success rates of new cancer therapies. The initiative represents a major step forward in personalized oncology care, with potential future implications for countries including Israel.